• Otilonium Bromide: Applied Antimuscarinic Agent in Neuroscie

  2026-05-09

  Otilonium Bromide, a high-purity antimuscarinic agent from APExBIO, enables robust and reproducible modulation of cholinergic signaling in neuroscience and smooth muscle models. This article spotlights practical workflows, troubleshooting strategies, and protocol optimizations that empower researchers to harness its full investigative potential.

• FGF19 Drives NPC Angiogenesis via TRIM21-ANXA2 Ubiquitinatio

  2026-05-09

  This study reveals that FGF19 promotes nasopharyngeal carcinoma (NPC) progression by enhancing angiogenesis through the inhibition of TRIM21-mediated ANXA2 ubiquitination. The findings illuminate a novel FGF19–TRIM21–ANXA2 pathway, suggesting potential biomarkers and therapeutic targets for NPC angiogenesis and early metastasis.

• Y-27632: Selective ROCK Inhibitor for Cytoskeletal Modulatio

  2026-05-08

  Y-27632 is a selective ROCK inhibitor widely used to modulate cytoskeletal dynamics in cell biology research. It disrupts actin stress fiber formation by inhibiting ROCK1 and ROCK2 with high specificity. APExBIO's Y-27632 (SKU B1293) enables reproducible manipulation of Rho-associated kinase signaling for applications in stem cell differentiation and cancer biology.

• Moxidectin: Macrocyclic Lactone Anthelmintic & Antifungal Sy

  2026-05-07

  Moxidectin is a macrocyclic lactone anthelmintic with proven efficacy in parasitic worm control and emerging evidence for antifungal synergy. Its mechanism involves binding glutamate-gated chloride channels in parasites and elevating ergosterol biosynthesis in Candida albicans, potentiating polyene antifungals. High-purity moxidectin from APExBIO enables translational research across veterinary and antifungal domains.

• Erlotinib in Translational Oncology: Mechanisms, Models, and

  2026-05-07

  This thought-leadership article explores how Erlotinib (NSC 718781) advances translational cancer research by dissecting its mechanistic role as an EGFR tyrosine kinase inhibitor, integrating recent findings on SCUBE3-mediated oncogenic signaling, and providing strategic guidance on rigorous experimental design. With direct comparison to antibody-based SCUBE3 targeting, the article contextualizes Erlotinib’s value in both preclinical models and future translational pipelines. Protocol and assay guidance is backed by current literature and workflow recommendations, with a focus on reproducibility and the evolving competitive landscape.

• Nile Red (Nile Blue Oxazone): Precision Lipid Droplet Visual

  2026-05-06

  Nile Red (Nile blue oxazone) is a widely used lipophilic fluorescent dye for intracellular lipid droplet staining and lipid metabolism research. Its dual-emission properties enable selective and quantitative analysis of lipid storage dynamics in diverse cell types. APExBIO’s Nile Red (B8209) offers high specificity and robust performance for biomedical investigations.

• GRK Subtype Control of M1 Receptor Signaling Bias Deciphered

  2026-05-06

  This study elucidates how distinct GRK subtypes regulate biased signaling at the M1 muscarinic acetylcholine receptor (M1 mAChR), with a focus on the molecular mechanisms underlying selective G protein and β-arrestin engagement. The findings provide quantitative insight into how allosteric modulators such as Benzyl Quinolone Carboxylic Acid (BQCA) fine-tune acetylcholine receptor signaling, offering critical context for Alzheimer's disease research and cognitive function modulation.

• Cytokine and Glucocorticoid Control of BIRC2/3 in Lung Epith

  2026-05-05

  This study delineates the differential regulatory mechanisms governing BIRC2 and BIRC3 expression in pulmonary epithelial cells under inflammatory and glucocorticoid stimuli. The findings clarify distinct roles for BIRC2 and BIRC3 in cell signaling, apoptosis regulation, and inflammatory response, offering mechanistic insights relevant to respiratory disease research.

• MG-132 in Hepatocellular Carcinoma: A Translational Perspect

  2026-05-05

  Explore how MG-132, a potent proteasome inhibitor, is shaping hepatocellular carcinoma research by enabling advanced apoptosis assays and cell cycle arrest studies. Uncover unique mechanistic insights, practical assay guidance, and pivotal findings from recent translational studies.

• Paroxetine: Multi-Target Mechanisms and Molecular Insights

  2026-05-04

  This review synthesizes the molecular mechanisms underlying paroxetine’s therapeutic action, emphasizing its selective serotonin reuptake inhibition and emerging multi-target pharmacology. By mapping its interactions with SERT, cytochrome P450 enzymes, and kinase pathways, the study informs both neuropsychiatric and oncology research, highlighting new translational opportunities.

• Pexidartinib (PLX3397): Redefining Macrophage Modulation in

  2026-05-04

  Explore how Pexidartinib (PLX3397) advances tumor microenvironment research through precise macrophage modulation and CSF1R-mediated signaling inhibition. This article offers a unique, evidence-driven perspective on translational assay design using PLX3397.

• pH-Mediated Ribociclib Interactions: QbD Assessment in Cance

  2026-05-03

  This study applies a Quality by Design (QbD) approach to rigorously assess the impact of acid-reducing agents on ribociclib’s solubility and absorption. The findings demonstrate that pH shifts induced by common acid-reducing therapies do not significantly compromise ribociclib’s pharmacokinetic profile, providing clarity for clinical co-administration and setting a benchmark for early-stage drug interaction assessment.

• Ceruletide Enables Precision Pancreatic Fibrosis Modeling

  2026-05-02

  Ceruletide (caerulein) is the gold standard for inducing reproducible pancreatic fibrosis and gastrointestinal motility changes in preclinical research. This guide translates cutting-edge mechanistic insights and practical troubleshooting tips into actionable workflows, helping scientists optimize experimental design and data reliability.

• Nystatin (Fungicidin): Advanced Antifungal Workflows & Troub

  2026-05-02

  Nystatin (Fungicidin) is a gold-standard antifungal agent with unique efficacy against Candida and Aspergillus species. This article translates bench findings into actionable workflows and troubleshooting, empowering researchers to optimize infection models and resistance studies using APExBIO’s rigorously validated compound.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Precision Proteasome Inhibiti

  2026-05-01

  MG-262 (Z-Leu-Leu-Leu-B(OH)2) is a potent, reversible, and cell-permeable proteasome inhibitor. This article details its mechanism, quantitative benchmarks, and relevance for apoptosis research, cell cycle arrest studies, and muscle proteostasis modeling. Cited literature and product documentation support its value in advanced proteasome inhibition assays.

16669 records 1/1112 page Next 12345 下5页 Last page